LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
A simple, precise, sensitive and validated reverse-phase high performance liquid chromatographic (RP-HPLC) method was developed for the simultaneous estimation of rosuvastatin and ezetimibe in human plasma. The method involved protein precipitation and extraction of both drugs from plasma using acet...
Guardado en:
Autores principales: | , , , |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Chilena de Química
2013
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072013000400059 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0717-97072013000400059 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0717-970720130004000592014-09-02LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMAASHFAQ,MUHAMMADAHMAD,HAMADKHAN,ISLAM ULLAHMUSTAFA,GHULAM HPLC Acetonitrile Diode Array Detector Rosuvastatin Ezetimibe A simple, precise, sensitive and validated reverse-phase high performance liquid chromatographic (RP-HPLC) method was developed for the simultaneous estimation of rosuvastatin and ezetimibe in human plasma. The method involved protein precipitation and extraction of both drugs from plasma using acetonitrile and then separation on a C-18 column. Both the analytes were detected at a wavelength of 240 nm using diode array detector. Mobile phase for the said separation consists of a mixture of 1.5% phosphoric acid and acetonitrile in 30:70, v/v ratio. Linearity was in the range of 0.32-267 mg/mL for rosuvastatin and 0.08-67 mg/mL for ezetimibe with coefficient of determination between 0.9997 and 0.9967. Limit of detection was 0.106 μg/mL for rosuvastatin and 0.026 mg/mL for ezetimibe whereas limit of quantification was 0.32 mg/mL and 0.08 mg/mL for rosuvastatin and ezetimibe respectively. Recovery of both the analytes was greater than 75% with RSD less than 15 %. The total run time was less than five min for the two components. The developed method can be fruitfully employed for the determination of these two drugs in human plasma.info:eu-repo/semantics/openAccessSociedad Chilena de QuímicaJournal of the Chilean Chemical Society v.58 n.4 20132013-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072013000400059en10.4067/S0717-97072013000400059 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
English |
topic |
HPLC Acetonitrile Diode Array Detector Rosuvastatin Ezetimibe |
spellingShingle |
HPLC Acetonitrile Diode Array Detector Rosuvastatin Ezetimibe ASHFAQ,MUHAMMAD AHMAD,HAMAD KHAN,ISLAM ULLAH MUSTAFA,GHULAM LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA |
description |
A simple, precise, sensitive and validated reverse-phase high performance liquid chromatographic (RP-HPLC) method was developed for the simultaneous estimation of rosuvastatin and ezetimibe in human plasma. The method involved protein precipitation and extraction of both drugs from plasma using acetonitrile and then separation on a C-18 column. Both the analytes were detected at a wavelength of 240 nm using diode array detector. Mobile phase for the said separation consists of a mixture of 1.5% phosphoric acid and acetonitrile in 30:70, v/v ratio. Linearity was in the range of 0.32-267 mg/mL for rosuvastatin and 0.08-67 mg/mL for ezetimibe with coefficient of determination between 0.9997 and 0.9967. Limit of detection was 0.106 μg/mL for rosuvastatin and 0.026 mg/mL for ezetimibe whereas limit of quantification was 0.32 mg/mL and 0.08 mg/mL for rosuvastatin and ezetimibe respectively. Recovery of both the analytes was greater than 75% with RSD less than 15 %. The total run time was less than five min for the two components. The developed method can be fruitfully employed for the determination of these two drugs in human plasma. |
author |
ASHFAQ,MUHAMMAD AHMAD,HAMAD KHAN,ISLAM ULLAH MUSTAFA,GHULAM |
author_facet |
ASHFAQ,MUHAMMAD AHMAD,HAMAD KHAN,ISLAM ULLAH MUSTAFA,GHULAM |
author_sort |
ASHFAQ,MUHAMMAD |
title |
LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA |
title_short |
LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA |
title_full |
LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA |
title_fullStr |
LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA |
title_full_unstemmed |
LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA |
title_sort |
lc determination of rosuvastatin and ezetimibe in human plasma |
publisher |
Sociedad Chilena de Química |
publishDate |
2013 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072013000400059 |
work_keys_str_mv |
AT ashfaqmuhammad lcdeterminationofrosuvastatinandezetimibeinhumanplasma AT ahmadhamad lcdeterminationofrosuvastatinandezetimibeinhumanplasma AT khanislamullah lcdeterminationofrosuvastatinandezetimibeinhumanplasma AT mustafaghulam lcdeterminationofrosuvastatinandezetimibeinhumanplasma |
_version_ |
1718445506755035136 |